Edition:
India

Nightstar Therapeutics PLC (NITE.OQ)

NITE.OQ on NASDAQ Stock Exchange Global Select Market

15.08USD
1:30am IST
Change (% chg)

$-1.07 (-6.63%)
Prev Close
$16.15
Open
$16.00
Day's High
$16.15
Day's Low
$14.80
Volume
6,423
Avg. Vol
7,812
52-wk High
$24.70
52-wk Low
$10.01

Chart for

About

Nightstar Therapeutics PLC, formerly Nightstar Therapeutics Limited, is a clinical-stage gene therapy company. The Company is focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases that would otherwise progress to blindness. The Company is developing a... (more)

Overall

Beta: --
Market Cap(Mil.): $470.69
Shares Outstanding(Mil.): 28.10
Dividend: --
Yield (%): --

Financials

BRIEF-Nightstar Therapeutics Starts Star Phase 3 Registrational Trial For Nsr-Rep1 In Choroideremia

* NIGHTSTAR THERAPEUTICS ANNOUNCES INITIATION OF STAR PHASE 3 REGISTRATIONAL TRIAL FOR NSR-REP1 IN CHOROIDEREMIA

05 Mar 2018

Earnings vs. Estimates